CORVUS PHARMACEUTICALS, INC. TRANSITION AND CONSULTING AGREEMENTTransition and Consulting Agreement • July 30th, 2020 • Corvus Pharmaceuticals, Inc. • Pharmaceutical preparations • California
THIS TRANSITION AND CONSULTING AGREEMENT (the “Agreement”) is made and entered into as of June 30, 2020, effective as of July 1, 2020 (the “Effective Date”), by and between CORVUS PHARMACEUTICALS, INC., a Delaware corporation having its principal place of business at 863 Mitten Road, Suite 102, Burlingame, CA 94010, USA (the “Company”), and Joseph Buggy, an individual with an address at 8154 Fallen Leaf Way, Truckee, CA 96161 ( “Consultant”). The Company and the Consultant may be referred to herein individually as “Party” or collectively, as “Parties.”
